Leylagül Kaynar

2.5k total citations
160 papers, 1.4k citations indexed

About

Leylagül Kaynar is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, Leylagül Kaynar has authored 160 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hematology, 35 papers in Genetics and 32 papers in Epidemiology. Recurrent topics in Leylagül Kaynar's work include Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (18 papers) and Antifungal resistance and susceptibility (16 papers). Leylagül Kaynar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (18 papers) and Antifungal resistance and susceptibility (16 papers). Leylagül Kaynar collaborates with scholars based in Türkiye, United States and United Kingdom. Leylagül Kaynar's co-authors include Bülent Eser, Mustafa Çetın, Ali Ünal, İsmail Koçyiğit, Serdar Şıvgın, Çiğdem Pala, Fatih Kurnaz, Sibel Hacıoğlu, Gökhan Metan and Muzaffer Keklık and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Leylagül Kaynar

142 papers receiving 1.3k citations

Peers

Leylagül Kaynar
Fevzi Altuntaş Türkiye
Jae Wook Lee South Korea
Fabrício Freire de Melo Brazil
Abigail Lamikanra United Kingdom
Daniela Weber Germany
Lili Tao China
Michael Schwameis Austria
Innocent T. Gangaidzo Zimbabwe
Brigitte Cantinieaux Belgium
Kamal Ivory United Kingdom
Fevzi Altuntaş Türkiye
Leylagül Kaynar
Citations per year, relative to Leylagül Kaynar Leylagül Kaynar (= 1×) peers Fevzi Altuntaş

Countries citing papers authored by Leylagül Kaynar

Since Specialization
Citations

This map shows the geographic impact of Leylagül Kaynar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leylagül Kaynar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leylagül Kaynar more than expected).

Fields of papers citing papers by Leylagül Kaynar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leylagül Kaynar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leylagül Kaynar. The network helps show where Leylagül Kaynar may publish in the future.

Co-authorship network of co-authors of Leylagül Kaynar

This figure shows the co-authorship network connecting the top 25 collaborators of Leylagül Kaynar. A scholar is included among the top collaborators of Leylagül Kaynar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leylagül Kaynar. Leylagül Kaynar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdala, Edson, Ümran Ertürk, Leylagül Kaynar, et al.. (2025). Comparative analysis of the nephrotoxicity of liposomal amphotericin B and amphotericin B lipid complex in hematological cancer patients: A multicenter retrospective study. Revista Iberoamericana de Micología. 42(2). 60–65.
2.
3.
Abdelhadi, Mohamed, et al.. (2025). Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report. Cureus. 17(7). e87513–e87513.
4.
Sevindik, Ömür Gökmen, Simten Dağdaş, Leylagül Kaynar, et al.. (2024). Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience. Leukemia Research. 140. 107484–107484. 2 indexed citations
5.
Kaynar, Leylagül, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma. Nigerian Journal of Clinical Practice. 27(12). 1405–1409.
6.
Gökahmetoğlu, Selma, et al.. (2023). Determination of Genotypes in Cytomegalovirus (CMV) Strains Obtained from Pediatric and Adult Immunocompromised Patients. Journal of Basic and Clinical Health Sciences. 7(1). 270–276. 1 indexed citations
7.
Alp, Emine, Zeynep Burçin Gönen, Kürşat Gündoğan, et al.. (2022). The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy. Emergency Medicine International. 2022. 1–9. 18 indexed citations
8.
Eren, Esma, et al.. (2020). The Outcome of Fungal Pneumonia with Hematological Cancer. Infection and Chemotherapy. 52(4). 530–530. 3 indexed citations
9.
Yeral, Mahmut, Can Boğa, Ali Ünal, et al.. (2020). A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma & Leukemia. 20(10). 652–660. 4 indexed citations
10.
Gökahmetoğlu, Selma, et al.. (2020). İmmün Yetmezlikli Hastalardan Elde Edilen Sitomegalovirüs İzolatlarındaki Gansiklovir Direncinin Araştırılması. Mikrobiyoloji Bulteni. 54(4). 619–628. 2 indexed citations
11.
Salihoğlu, Ayşe, Teoman Soysal, Ìhsan Karadoǧan, et al.. (2019). Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Annals of Hematology. 99(2). 301–307. 5 indexed citations
12.
Metan, Gökhan, et al.. (2017). A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.. PubMed. 25(1). 33–37. 4 indexed citations
13.
Taşdemir, Şener, et al.. (2015). Does the Level of WT1 Expression Predict the Outcome in Philadelphia-Negative Myeloproliferative Neoplasms?. Genetic Testing and Molecular Biomarkers. 19(4). 222–224. 1 indexed citations
14.
Kendırcı, Mustafa, et al.. (2015). Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood. Transfusion and Apheresis Science. 54(2). 282–288. 3 indexed citations
15.
Keklık, Muzaffer, Serdar Şıvgın, Kemal Denız, et al.. (2013). Coincidence of three solid tumors in a patient with multiple myeloma. Chinese Medical Journal. 126(6). 1186–1187. 2 indexed citations
16.
Baldane, Süleyman, Muzaffer Keklık, Leylagül Kaynar, et al.. (2013). The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?. Transplantation Proceedings. 45(9). 3371–3374. 11 indexed citations
17.
Kanda, Junya, Leylagül Kaynar, Yoshinobu Kanda, et al.. (2013). Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplantation. 48(7). 926–931. 37 indexed citations
18.
Metan, Gökhan, et al.. (2011). Can bacteraemia lead to false positive results in 1,3-beta-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Revista Iberoamericana de Micología. 29(3). 169–171. 25 indexed citations
19.
Metan, Gökhan, Ayşe Nedret Koç, Leylagül Kaynar, et al.. (2011). What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?. Scandinavian Journal of Infectious Diseases. 44(5). 330–336. 19 indexed citations
20.
Sipahioğlu, Murat Hayri, Fevzi Altuntaş, Leylagül Kaynar, et al.. (2009). Primary brain T-cell lymphoma concomitant with CNS tuberculosis in a kidney transplant patient.. 31(3). 256–260. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fevzi Altuntaş Breakdown of academic impact, for papers by Jae Wook Lee Breakdown of academic impact, for papers by Fabrício Freire de Melo Breakdown of academic impact, for papers by Abigail Lamikanra Breakdown of academic impact, for papers by Daniela Weber Breakdown of academic impact, for papers by Lili Tao Breakdown of academic impact, for papers by Michael Schwameis Breakdown of academic impact, for papers by Innocent T. Gangaidzo Breakdown of academic impact, for papers by Brigitte Cantinieaux Breakdown of academic impact, for papers by Kamal Ivory
Rankless by CCL
2026